Human Vaccines & Immunotherapeutics

Papers
(The TQCC of Human Vaccines & Immunotherapeutics is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance338
Attitudes of school teachers toward influenza and COVID-19 vaccine in Greece during the COVID-19 pandemic295
Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study255
Reasons underlying the intention to vaccinate children aged 5-11 against COVID-19: A cross-sectional study of parents in Israel, November 2021144
COVID-19 vaccines associated with vasovagal malaise: A retrospective study in two mass vaccination centers and analysis of the WHO pharmacovigilance database127
Human vaccines & immunotherapeutics: News October 2022122
Effects of a web-based HPV vaccination intervention on cognitive outcomes among young gay, bisexual, and other men who have sex with men116
Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria116
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary94
Expanding access to COVID-19 testing, vaccination and treatment at a free clinic for uninsured Spanish-speaking adults in Providence, RI84
Human vaccines & immunotherapeutics: News August 202276
Human Vaccines & immunotherapeutics: News, June 202274
Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 970
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children64
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial63
RNA vaccines: The dawn of a new age for tuberculosis?60
Prevention of herpes zoster in acquired immunocompromised conditions: Review of updates and perspectives from Hong Kong59
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study59
Evaluating the impact of the vaccination prescription program on herpes zoster vaccine coverage in Ningbo, China: An interrupted time series analysis59
Patient preferences toward herpes zoster vaccination among individuals aged 50 years or older in South Korea: Findings from a discrete choice experiment57
Intention to get COVID-19 vaccines: Exploring the role of attitudes, subjective norms, perceived behavioral control, belief in COVID-19 misinformation, and vaccine confidence in Northern India57
Expanding vaccination provider types and administration sites can increase vaccination uptake: A systematic literature review of the evidence in non-United States geographies57
A qualitative investigation of facilitators and barriers to accessing COVID-19 vaccines among Racialized and Indigenous Peoples in Canada56
Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers’ attitudes and practices56
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling55
Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China54
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012–2023)52
Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model52
Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines52
60 Years of viral vaccines50
Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: A retrospective cohort study in Italy50
A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients46
Vaccine manufacturing is essential to ensure access46
Predictive factors of neoadjuvant immune checkpoint blockade in melanoma45
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China45
Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China45
Heterologous mRNA-based COVID-19 booster strategies: Comment45
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in43
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control43
Integrating civil liberty and the ethical principle of autonomy in building public confidence to reduce COVID-19 vaccination inequity in Africa42
Reply to the letter to the editor titled “Guillain-Barre / Miller-Fisher overlap syndrome or acute, motor and sensory, axonal neuropathy with cranial nerve involvement?”41
Human Vaccines & Immunotherapeutics: News April 202340
Pneumococcal vaccines in China39
I have decided about my COVID-19 vaccine, what about my child?39
Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention39
Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines’ immunogenicity39
Emerging trends of research on mRNA vaccines: A co-citation analysis38
Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges38
Addressing COVID-19 vaccine hesitancy38
Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines37
Obituary of Robert Daum - Expert in Staphylococcal Disease36
The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)36
Quality over quantity: human papillomavirus vaccine information on social media and associations with adult and child vaccination36
Human Vaccines & Immunotherapeutics: News May 202235
Reply letter to the editor concerning the article ‘Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance’35
A comparison of the test-negative and the matched case-control study designs for estimation of EV71 vaccine immunological surrogate endpoints from a randomized controlled trial35
Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice35
Human papillomavirus vaccination coverage and knowledge, perceptions and influencing factors among university students in Guangzhou, China34
Yellow fever virus vaccination: an emblematic model to elucidate robust human immune responses34
Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’34
Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico32
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies32
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain32
COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies32
Determinants of basic childhood vaccination coverage in European and OECD countries31
Waning of maternal antibody against measles virus in Shufu, China31
Formulation development of a stable influenza recombinant neuraminidase vaccine candidate31
Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized contro31
A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific30
Decoding trends in mRNA vaccine research: A comprehensive bibliometric study30
Knowledge, attitudes, and practices of the general population, herpes zoster patients, and dermatologists toward herpes zoster in China: A quantitative cross-sectional survey30
Human papillomavirus vaccination at the first opportunity: An overview30
Attitudes toward influenza vaccination in healthcare workers in Italy: A systematic review and meta-analysis30
Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen30
Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized tria30
Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) 29
Is ‘original antigenic sin’ complicating indian vaccination drive against Covid-19?29
Human vaccines & immunotherapeutics: news October 202129
Human Vaccines & Immunotherapeutics: News29
Human vaccines & immunotherapeutics news: July 202029
Temporary vaccination clinic for COVID-19 in Zhuhai, China29
Reply letter to “safety of SARS-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance”28
Human vaccines & immunotherapeutics: news28
Information in Spanish on YouTube about Covid-19 vaccines28
Letter from the editor28
Immunogenicity and safety of Ebola virus vaccines in healthy adults: a systematic review and network meta-analysis28
Letter to the editor in response to: Rotavirus vaccine administration patterns in Italy: potential impact on vaccine coverage, compliance and adherence28
Research trends in rabies vaccine in the last three decades: a bibliometric analysis of global perspective27
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-1927
Nano alum: A new solution to the new challenge27
Trends in hepatitis A research indexed in the Web of Science: a bibliometric analysis over the period from 1985 to 201927
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence27
How does the immunogenicity of hepatitis B vaccine change over the years in childhood?27
The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic26
Parents’ attitudes toward children’s vaccination as a marker of trust in health systems26
A potential means to help the HPV vaccine penetrate the Japanese public while under the continued suspension of governmental recommendation26
Assessing acceptability of the fourth dose against COVID-19 among Chinese adults: A population-based survey26
HPV prevalence and genotype distribution among women in eastern China during the Covid-19 pandemic26
Association of vaccine policy with virus infection and awareness of hepatitis B in Fujian, China26
India and the COVID-19 vaccine26
The intention to get a COVID-19 vaccine among the students of health science in Vietnam25
Risk factors for carriage of meningococcus in third-level students in Ireland: an unsupervised machine learning approach25
Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review25
COVID-19 and second wave: can India become self-sufficient in vaccines?25
Long-term immunity and the effect of one or two booster doses with a lyophilized human rabies vaccine (human diploid cells) at 10 years post primary vaccination in China25
The influenza vaccine for nursing and care professionals at emergency services in Flanders25
Human vaccines and immunotherapeutics: News March 202424
Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients24
Human papillomavirus vaccination coverage among young women in the three sub-Saharan African countries using Demographic and Health Surveys data24
Intraneural ganglion cyst of the peroneal nerve and coronavirus disease-19 vaccination: Relationship and possible mechanism23
Real-world data of China: Analysis of HPV vaccine coverage and post-vaccination adverse reaction monitoring in Western Chinese provinces from 2018 to 202123
Enhanced immunity against SARS-CoV-2 in returning Chinese individuals23
The critical factors for COVID-19 vaccination uptake are perceived ‎vaccine effectiveness and the desire to protect others23
Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence23
Efficacy of HBV booster dose administration in Italian medical students in relation to health determinants23
Human vaccines and immunotherapeutics: News September 202323
Awareness of and attitude toward COVID-19 vaccination among individuals with COPD and the strategies to overcome vaccine hesitation: A mini review23
Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities23
Immunity to measles in COVID-19 era23
COVID-19 and flu vaccinations among medical residents in a tertiary hospital in Italy: Correspondence23
Multi-epitope mRNA vaccine candidate to combat HMPV virus: Comment22
How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? – evidence from Nigeria22
A worldwide overview for hexavalent vaccines and a glimpse into Turkiye’s perspective22
Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine: Comment22
Parents and teachers’ perspectives on a school-located influenza vaccination program: A pilot study in the Region of Murcia, Spain22
Human vaccines and immunotherapeutics: News December 202322
Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010–22
Medical students’ knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer22
Caregivers’ hesitancy and outright refusal toward children’s COVID-19 vaccination in the Democratic Republic of Congo: A community-based cross-sectional study22
Correction22
Exploring risk factors for endocrine-related immune-related adverse events: Insights from meta-analysis and Mendelian randomization22
Impact of COVID-19 pandemic on influenza vaccination rate among health care workers22
Response to comment on “A bibliometric analysis of vaccination against atherosclerosis”22
Facilitators and barriers to maternal immunization and strategies to improve uptake in low-income and lower-middle income countries: A systematic review22
“I’d just love to hear what the community has to say”: Exploring the potential of community-driven vaccine messaging amongst ethnic minority communities21
Knowledge about, attitudes toward and acceptance and predictors of intention to receive the mpox vaccine among cancer patients in China: A cross-sectional survey21
Editorial to special issue “The power of immunoprofiling supported by computational data integration and machine learning”21
Comparison of T cells mediated immunity and side effects of mRNA vaccine and conventional COVID-19 vaccines administrated in Jordan21
Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review21
Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy21
Comment on the “Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao’an district of She21
Politics and confidence toward the COVID-19 vaccination: Points to be considered21
Development and validation of a COVID-19 vaccination prediction model based on self-reporting results in Chinese older adults from September 2022 to November 2022: A nationwide cross-sectional study21
A case of congenital rubella syndrome and epidemiology of related cases in China, 2014–202321
Immunogenicity and immune persistence of Zagreb 2-1-1 regimen of rabies vaccine in Chinese healthy individuals: A randomized, parallel-controlled of homologous vaccine with different immune procedure 20
Hypophysitis after COVID-19 vaccination in a patient with Rathke’s cleft cyst: A case report20
Positioning implementation science in national immunization programmes to improve coverage equity and advance progress toward Immunization Agenda 2030: An urgent global health imperative20
Characteristics of measles antibodies in premature infants: Comment20
Rotavirus vaccine dose-two dropout and its associated factors among children who received rotavirus vaccine dose-one in Sub-Saharan African countries: A multilevel analysis of the recent demographic a20
Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia20
Human vaccines and immunotherapeutics: News November 202420
Reduced risk of CIN2+ recurrence in women immunized with a 9-valent HPV vaccine post-excision: Retrospective cohort study20
Analysis of sero-epidemiological characteristics of varicella in healthy children in Wuxi, China19
Is informed consent correctly obtained for vaccinations?19
Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine19
Cost-effectiveness analysis of introducing rotavirus vaccine into immunization program in Zhejiang province, China: A decision tree-Markov model study19
Deceptive tactics: Misappropriation of scientific literature by ‘Gazeta do Povo’ in undermining COVID-19 vaccination efforts19
Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children19
Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models19
The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review19
Factors influencing vaccine acceptance in pregnancy during the COVID-19 pandemic: A multicenter study from West Bengal, India19
Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region19
Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China19
Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents19
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases19
Factors determining first influenza vaccination among individuals with type 2 diabetes in the CONSTANCES cohort by age group (younger than 65 years or 65 and older)18
Current status of immunisation for herpes zoster18
Investigation of factors affecting COVID-19 vaccine acceptance among communities of universities in the United Arab Emirates18
Nosocomial acute gastroenteritis outbreak caused by an equine-like G3P[8] DS-1-like rotavirus and GII.4 Sydney[P16] norovirus at a pediatric hospital in Rio de Janeiro, Brazil, 201918
The nature and severity of SARS-CoV-2 vaccine side effects in athletes are highly dependent on study design18
From PD-1/PD-L1 to tertiary lymphoid structures: Paving the way for precision immunotherapy in cholangiocarcinoma treatment18
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review18
HPV vaccine knowledge, attitudes, and practices among New York State medical providers, dentists, and pharmacists18
Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018–2019 season18
Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in18
Effects of a multimedia campaign to increase human papillomavirus vaccine acceptance in Dhaka, Bangladesh18
Plasma therapy: a passive resistance against the deadliest18
Unveiling and addressing implementation barriers of vaccination communication strategy: Perspectives from government officials at national and provincial levels18
Joint consensus on reducing the burden of invasive meningococcal disease in the Asia-Pacific region18
Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review18
Vaccination therapy for inflammatory bowel disease17
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children17
An ethics of HPV vaccination: beyond principlism17
Novel malaria vaccines17
Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer17
Letter to the editor: Backdrop context of the study “Intention to vaccinate young children against COVID-19: a large-scale survey of Hong Kong parents”17
Parental perceptions, attitudes, and beliefs regarding vaccination of children aged 0–5 years: A qualitative study of hill-tribe communities, Thailand17
Mpox vaccination for men who have sex with men17
Measles vaccine uptake among Italian medical students compared to the pre-COVID-19 era17
Comparison of self-reported symptoms in COVID-19 patients who had or had not previously received COVID-19 mRNA vaccination17
COVID-19 vaccination intention among nursing, medical, and dental students: A systematic review and meta-regression analysis17
Heterologous COVID-19 vaccination in pregnant women: Comment17
Self-reported side effects following COVID-19 vaccination in athletes: Correspondence17
Homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: Comment17
Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants17
Factors affecting the acceptability of COVID-19 vaccine in the postpartum period17
COVID-19 clinical trial participation and awareness in Texas16
End of season 2022/2023 quadrivalent influenza vaccine effectiveness in preventing influenza in primary care in Portugal16
Beyond intention: Predicting children’s COVID-19 vaccine uptake using the theory of planned behavior16
Knowledge mapping of trained immunity/innate immune memory: Insights from two decades of studies16
High rates of vaccine hesitancy among pregnant women during the coronavirus disease 2019 (COVID-19) pandemic in Japan16
Clinical and economic burden of otitis media in children under 5 years of age in the United States: A retrospective study16
Dual-antigen fusion protein vaccination induces protective immunity against Candida albicans infection in mice16
Enhancing COVID-19 booster vaccination among the elderly through text message reminders16
Improving Tdap maternal immunization rate in Saudi Arabia16
From defense to offense: Modulating toll-like receptors to combat arbovirus infections16
Epidemiological characteristics of breakthrough mumps infection cases from 2019 to 2023 in Chongqing, China16
Evaluation of influenza vaccination coverage in Shanghai city during the 2016/17 to 2020/21 influenza seasons16
Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China16
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality16
Syphilis vaccine development: Aligning vaccine design with manufacturing requirements16
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak16
A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus i16
Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer16
Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotype16
The association between influenza vaccination and the perception of COVID-19 as well as COVID-19 vaccination behavior among community residents in Anhui province, China16
Antibody dynamics for heterologous boosters with aerosolized Ad5-nCoV following inactivated COVID-19 vaccines16
Human papillomavirus (HPV) trials: A cross-sectional analysis of clinical trials registries16
The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age16
Do vaccinations influence the development of Alzheimer disease?16
Assessing the determinants of influenza and COVID-19 vaccine co-administration decisions in the elderly16
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer15
How to make effective HPV vaccine recommendations starting at age 915
Bivalent second booster dose of the COVID-19 vaccine: Eligible populations’ reasons for receiving in Italy15
Health economic evaluation of 2-dose and 3-dose rotavirus vaccines in children below 5 years of age in Morocco15
Treatment-prognostication-adjustment a new therapeutic idea by analyzing T cell immune checkpoint in tumor microenvironment by algorithm: A bibliometric analysis15
Uncertainty and unwillingness to receive a COVID-19 vaccine in adults residing in Puerto Rico: Assessment of perceptions, attitudes, and behaviors15
Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study15
Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study15
Community based participatory research as a promising practice for addressing vaccine hesitancy, rebuilding trust and addressing health disparities among racial and ethnic minority communities15
Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study15
Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial15
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy15
Recommendations and Health Technology Assessment (HTA) landscape evaluation for pediatric pneumococcal conjugate vaccines (PCV) in Europe: A systematic literature review15
Attitudes towards HPV and COVID school-entry policies among adults living in Puerto Rico15
Public health impact of 2-, 4-, and 9-valent HPV vaccination in females on cervical and noncervical diseases in men and women under different coverage scenarios in China: A simulation study15
Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review15
Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis15
High vaccine confidence and strong approval of the mandatory immunization schedule among Bulgarian general practitioners in 202215
How can COVID-19 vaccines benefit people? A study based on the theory of the commons15
4CMenB journey to the 10-year anniversary and beyond15
Effectiveness of HPV vaccine as part of national immunization program for preventing HPV infection in Thai schoolgirls after seven years post-vaccination15
A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants15
Vaccinated or not? Survey on attitude toward ‘approach-avoidance conflict’ under uncertainty15
A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flaviviru15
Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate15
mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic14
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons14
Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, plac14
A randomized clinical trial of the impact of melatonin on influenza vaccine: Outcomes from the melatonin and vaccine response immunity and chronobiology study (MAVRICS)14
0.14519214630127